Target intelligence / Profile preview

Serine protease 45, pseudogene (PRSS45P)

Target: PRSS45P
Molecular classification: Pseudogene, proteinase pseudogene, serine protease family (predicted)

Overview

Serine protease 45, pseudogene (PRSS45P) is a predicted pseudogene in humans, also previously named "serine protease 45". While annotated as part of the serine protease gene family, PRSS45P is not believed to encode a functional protein product. Pseudogenes are DNA sequences similar to functional genes but are generally nonfunctional due to mutations or the absence of regulatory elements. PRSS45P is thus not considered a therapeutic target and has no known role in human biology or disease. Any associations with serine-type endopeptidase activity are hypothetical and based on sequence homology, not experimental evidence.

Other names: Serine protease 45PRSS45testis serine protease 5TESPLTESSP5

Beyond the preview

Go deeper on Serine protease 45, pseudogene (PRSS45P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Serine protease 45, pseudogene (PRSS45P).

Explore the full profile